Your browser doesn't support javascript.
loading
Ketamine use for management of vaso-occlusive pain in pediatric sickle cell disease.
Harris, Emily M; Vilk, Emily; Donado, Carolina; Williams, Alexis; Heeney, Matthew M; Solodiuk, Jean; Greco, Christine; Archer, Natasha M.
Affiliation
  • Harris EM; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.
  • Vilk E; Division of Hematology, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Donado C; Division of Hematology, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Williams A; Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Heeney MM; Department of Anaesthesia, Harvard Medical School, Boston, Massachusetts, USA.
  • Solodiuk J; Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Greco C; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.
  • Archer NM; Division of Hematology, Boston Children's Hospital, Boston, Massachusetts, USA.
Pediatr Blood Cancer ; 70(5): e30254, 2023 05.
Article in En | MEDLINE | ID: mdl-36861789
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anemia, Sickle Cell / Ketamine Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Humans Language: En Journal: Pediatr Blood Cancer Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anemia, Sickle Cell / Ketamine Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Humans Language: En Journal: Pediatr Blood Cancer Year: 2023 Document type: Article